Back
Rhythm Pharmaceuticals Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
RYTM
Rhythm Pharmaceuticals
Last Price:
$49.79
Seasonality Move:
6%
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Rhythm Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.02 | Sell |
| 20-day SMA: | 52.41 | Sell |
| 50-day SMA: | 55.15 | Sell |
| 200-day SMA: | 52.1 | Sell |
| 8-day EMA: | 52.54 | Sell |
| 20-day EMA: | 53.03 | Sell |
| 50-day EMA: | 54.27 | Sell |
| 200-day EMA: | 51.54 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.62 | Sell |
| Relative Strength Index (14 RSI): | 46.71 | Sell |
| Chaikin Money Flow: | 628121 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.13 - 54.07) | Sell |
| Bollinger Bands (100): | (53.24 - 60.24) | Sell |
Rhythm Pharmaceuticals Technical Analysis
| Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 51.96 while RYTM 8-day simple moving average is 53.02, which is a Sell signal.
-
The stock price of RYTM is 51.96 while Rhythm Pharmaceuticals 20-day SMA is 52.41, which makes it a Sell.
-
Rhythm Pharmaceuticals 50-day simple moving average is 55.15 while RYTM share price is 51.96, making it a Sell technically.
-
RYTM stock price is 51.96 and Rhythm Pharmaceuticals 200-day simple moving average is 52.10, creating a Sell signal.
RYTM Technical Analysis vs Fundamental Analysis
Sell
40
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a SellThe current Rhythm Pharmaceuticals [RYTM] share price is $51.96. The Score for RYTM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
3.3B
Price in USD:
51.96
Share Volume:
783.3K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
68.58
52-Week Low:
35.17
Sell
40
Rhythm Pharmaceuticals (RYTM)
is a Sell
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?The Rhythm Pharmaceuticals stock price is 51.96 USD today.
-
Will RYTM stock go up or go down?Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rhythm Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 51.96 while RYTM 8-day exponential moving average is 52.54, which is a Sell signal.
-
The stock price of RYTM is 51.96 while Rhythm Pharmaceuticals 20-day EMA is 53.03, which makes it a Sell.
-
Rhythm Pharmaceuticals 50-day exponential moving average is 54.27 while RYTM share price is 51.96, making it a Sell technically.
-
RYTM stock price is 51.96 and Rhythm Pharmaceuticals 200-day simple moving average is 51.54, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.06 per share, an increase this year of $1.60 per share, and an increase next year of $1.16 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
-
RYTM Moving Average Covergence Divergence (MACD) indicator is -0.62, suggesting Rhythm Pharmaceuticals is a Sell
-
Rhythm Pharmaceuticals Relative Strength Index (RSI) is 46.71, which suggest Rhythm Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Rhythm Pharmaceuticals is (51.13 - 54.07), which suggest Rhythm Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Rhythm Pharmaceuticals is (53.24 - 60.24), which suggest Rhythm Pharmaceuticals is a Sell
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.